Ionis Pharmaceuticals, Inc.
- IONS
- NASDAQ
- Biotechnology
- RNA-Targeted Therapies
- Antisense Oligonucleotides
$42.94
Today −2.67%Quote Oct 16, 2026, 08:00 PM UTC
−8.15%over the last month
Max drawdown −9.3%From 1-month high −8.1%3 months −18.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$7.14B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$84.38
+96.5% from here
Floor
$42.54
0.9% below price
Where the price sits
33 analysts
Analyst range, low to high
$54.00$115.00
- Price $42.94
- Resistance $43.37
- Consensus $84.38
The price is just above its floor and right under resistance. Analysts' average target sits about 97% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IONSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $267.9M
- Commercial Member$118.6M44.3%
- Royalty$76.0M28.3%
- Product$31.1M11.6%
- Other / not reported$42.2M15.8%
Industry
Biotechnology
Employees
1,480
Founded
1989